User profiles for Tom Solomon
Tom SolomonUniversity of Liverpool Verified email at liv.ac.uk Cited by 42784 |
Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study
Background Concerns regarding potential neurological complications of COVID-19 are being
increasingly reported, primarily in small series. Larger studies have been limited by both …
increasingly reported, primarily in small series. Larger studies have been limited by both …
[HTML][HTML] Neurological associations of COVID-19
…, R Kneen, S Defres, J Sejvar, T Solomon - The Lancet …, 2020 - thelancet.com
Background The COVID-19 pandemic, caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is of a scale not seen since the 1918 influenza pandemic. Although …
coronavirus 2 (SARS-CoV-2), is of a scale not seen since the 1918 influenza pandemic. Although …
Virology, epidemiology, pathogenesis, and control of enterovirus 71
First isolated in California, USA, in 1969, enterovirus 71 (EV71) is a major public health
issue across the Asia-Pacific region and beyond. The virus, which is closely related to …
issue across the Asia-Pacific region and beyond. The virus, which is closely related to …
[PDF][PDF] SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses
…, CJ Sands, JT Scott, L Sigfrid, T Solomon… - Cell, 2022 - cell.com
On 24 th November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B.1.1.529
was announced, containing far more mutations in Spike (S) than previously reported …
was announced, containing far more mutations in Spike (S) than previously reported …
[HTML][HTML] Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination
Background The mainstay of control of the coronavirus disease 2019 (Covid-19) pandemic
is vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). …
is vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). …
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C …
Objective To develop and validate a pragmatic risk score to predict mortality in patients admitted
to hospital with coronavirus disease 2019 (covid-19). Design Prospective observational …
to hospital with coronavirus disease 2019 (covid-19). Design Prospective observational …
[HTML][HTML] Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study
…, M Zuckerman, KJ Mutton, T Solomon… - The Lancet infectious …, 2010 - thelancet.com
Background Encephalitis has many causes, but for most patients the cause is unknown. We
aimed to establish the cause and identify the clinical differences between causes in patients …
aimed to establish the cause and identify the clinical differences between causes in patients …
Clinical features, diagnosis, and management of enterovirus 71
…, P Lewthwaite, MJ Cardosa, T Solomon - The Lancet …, 2010 - thelancet.com
Although poliomyelitis has been mostly eradicated worldwide, large outbreaks of the related
enterovirus 71 have been seen in Asia-Pacific countries in the past 10 years. This virus …
enterovirus 71 have been seen in Asia-Pacific countries in the past 10 years. This virus …
[PDF][PDF] Estimated global incidence of Japanese encephalitis: a systematic review
…, JM Hombach, AA Marfin, T Solomon… - Bulletin of the World …, 2011 - SciELO Public Health
OBJECTIVE: To update the estimated global incidence of Japanese encephalitis (JE) using
recent data for the purpose of guiding prevention and control efforts. METHODS: Thirty-two …
recent data for the purpose of guiding prevention and control efforts. METHODS: Thirty-two …
[HTML][HTML] Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP …
Background Microbiological characterisation of co-infections and secondary infections in
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …